Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population

Drug and Alcohol Dependence

Volumn 119, Issue 1-2, 2011, Pages 28-36

  Martins, Silvia S ^a   Gorelick, David A ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Conditional abuse; Conditional substance dependence; Psychiatric comorbidity; Self medication hypothesis

Indexed keywords

ADULT; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MOOD DISORDER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; UNITED STATES;

ADULT; ALCOHOLISM; ANXIETY DISORDERS; COMORBIDITY; DATABASES, FACTUAL; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MENTAL DISORDERS; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; UNITED STATES;

CANNABIS SATIVA;

EID: 80055013698     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.05.010     Document Type: Article

References (46)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
2. Anthony J.C., Warner L.A., Kessler R.C. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 1994, 2:244-268.
3. Buckley P.F., Brown E.S. Prevalence and consequences of dual diagnosis. J. Clin. Psychiatry 2006, 67:e01.
4. Canino G., Bravo M., Ramírez R., Febo V.E., Rubio-Stipec M., Fernández R.L., Hasin D. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J. Stud. Alcohol 1999, 60:790-799.
5. Compton W.M., Thomas Y.F., Stinson F.S., Grant B.F. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2007, 64:566-576.
6. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 2004, 5:2114-2121.
7. Conway K.P., Compton W., Stinson F.S., Grant B.F. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 2006, 67:247-257.
8. Conway K.P., Montoya I.D., Compton W. Lifetime psychiatric comorbidity of illicit drug use disorders. Psychiatr. Times 2007, 24:4.
9. Degenhardt L., Bohnert K.M., Anthony J.C. Case ascertainment of alcohol dependence in general population surveys: 'gated' versus 'ungated' approaches. Int. J. Methods Psychiatr. Res. 2007, 16:111-123.
10. Degenhardt L., Bohnert K.M., Anthony J.C. Assessment of cocaine and other drug dependence in the general population: "gated" versus "ungated" approaches. Drug Alcohol Depend. 2008, 93:227-232.
11. de Leon J., Diaz F. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 2005, 76:135-157.
12. Dixon L., Postrado L., Delahanty J., Fischer P.J., Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. J. Nerv. Ment. Dis. 1999, 187:496-502.
13. Eaton W.W., Martins S.S., Nestadt G., Bienvenu O.J., Clarke D., Alexandre P.K. The burden of mental disorders. Epidemiol. Rev. 2008, 30:1-14.
14. Ehlers C.L., Wall T.L., Corey L., Lau P., Gilder D.A., Wilhelmsen K. Heritability of illicit drug use and transition to dependence in Southwest California Indians. Psychiatr. Genet. 2007, 17:171-176.
15. Fowler T., Lifford K., Shelton K., Rice F., Thapar A., Neale M.C., McBride A., van den Bree M.B. Exploring the relationship between genetic and environmental influences on initiation and progression of substance use. Addiction 2007, 102:413-422.
16. Grant B.F. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J. Subst. Abuse 1995, 7:481-497.
17. Grant B.F. DSM-IV, DSM-III-R, and ICD-10 alcohol and drug abuse/harmful use and dependence, United States 1992 a nosological comparison. Alcohol. Clin. Exp. Res. 1996, 20:1481-1488.
18. Grant B.F., Moore T.C., Shepard J., Kaplan K. Source and accuracy statement for wave 1 of the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions 2003, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD. http://niaaa.census.gov/pdfs/source_and_accuracy_statement.pdf.
19. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
20. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., Ruan W.J., Goldstein R.B., Smith S.M., Saha T.D., Huang B. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol. Med. 2005, 35:1747-1759.
21. Gregg L., Barrowclough C., Haddock G. Reasons for increased substance use in psychosis. Clin. Psychol. Rev. 2007, 27:494-510.
22. Grucza R.A., Abbachi A.M., Pryzbeck T.R., Gfroerer J.C. Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction 2007, 102:623-629.
23. Hasin D.S., Goodwin R.D., Stinson F.S., Grant B.F. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch. Gen. Psychiatry 2005, 62:1097-1106.
24. Hasin D., Carpenter K.M., McCloud S., Smith M., Grant B.F. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997, 14:133-141.
25. Heiman G.A., Ogburn E., Gorrochurn P., Keyes K.M., Hasin D. Evidence for a two-stage model of dependence using the NESARC and its implications for genetic association studies. Drug Alcohol Depend. 2008, 92:258-266.
26. Jane-Llópis E., Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006, 25:515-536.
27. Kalaydjian A., Swendsen J., Chiu W.T., Dierker L., Degenhardt L., Glantz M., Merikangas K.R., Sampson N., Kessler R. Sociodemographic predictors of transitions across stages of alcohol use, disorders, and remission in the National Comorbidity Survey Replication. Compr. Psychiatry 2009, 50:299-306.
28. Kandel D., Chen K., Warner L.A., Kessler R.C., Grant B. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug Alcohol Depend. 1997, 44:11-29.
29. Kandel D.B., Johnson J.G., Bird H.R., Canino G., Goodman S.H., Lahey B.B., Regier D.A., Schwab-Stone M. Psychiatric disorders associated with substance use among children and adolescents: findings from the methods for the epidemiology of child and adolescent mental disorders (MECA) study. J. Abnorm. Child Psychiatry 1997, 25:121-132.
30. Kendler K.S., Myers J., Prescott C.A. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch. Gen. Psychiatry 2007, 64:1313-1320.
31. Kessler R.C. The epidemiology of dual diagnosis. Biol. Psychiatry 2004, 56:730-737.
32. Kessler R.C., Aguilar-Gaziola S., Andrade L., Bijl R., Borges L.G., Caraveo-Anduaga J.J., DeWit D.J., Kolody B., Merikangas K.R., Molnar B.R., Vega W.A., Walters E.E., Wittchen H. Cross-national comparisons of co-mordibities between substance use disorders and mental disorders. Handbook of Drug Abuse Prevention: Theory, Science, and Practice 2003, Kluwer Academic Publishers, New York, pp. 447-472. Z. Sloboda, W.J. Bukoski (Eds.).
33. Khantzian E.J. The self-medication hypothesis revisited: the dually diagnosed patient. Prim. Psychiatry 2003, 10:47-54.
34. Kraemer H.C., Wilson K.A., Hayward C. Lifetime prevalence and pseudocomorbidity in psychiatric research. Arch. Gen. Psychiatry 2006, 63:604-608.
35. Lammertink M., Lohrer F., Kaiser R., Hambrecht M., Pukrop R. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse. Acta Psychiatr. Scand. 2001, 104:361-366.
36. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-332.
37. Perkonigg A., Lieb R., Wittchen H.U. Prevalence of use, abuse and dependence of illicit drugs among adolescents and young adults in a community sample. Eur. Addict. Res. 1998, 4:58-66.
38. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990, 264:2511-2518.
39. Rounsaville B.J., Kosten T.R., Weissman M.M., Prusoff B., Pauls D., Anton S.F., Merikangas K. Psychiatric disorders in relatives of probands with opiate addiction. Arch. Gen. Psychiatry 1991, 48:33-42.
40. Sartor C.E., Agrawal A., Lynskey M.T., Bucholz K.K., Heath A.C. Genetic and environmental influences on the rate of progression to alcohol dependence in young women. Alcohol. Clin. Exp. Res. 2008, 32:632-638.
41. Schneier F.R., Siris S.G. A review of psychoactive substance use and abuse in schizophrenia Patterns of drug choice. J. Nerv. Ment. Dis. 1987, 174:641-652.
42. StataCorp Stata Statistical Software: Release 10.0 2007, Stata Corporation, College Station, TX.
43. Substance Abuse and Mental Health Services Administration, 2003. Results from the 2002 National Household Survey on Drug Abuse, vol. II. Technical appendices and selected data tables (Office of Applied Studies, NHSDA Series H-22, DHHS Publication No. SMA 03-3836): SAMSHA. Rockville, MD.
44. Swendsen J., Anthony J.C., Conway K.P., Degenhardt L., Dierker L., Glantz M., He J., Kalaydjian A., Kessler R.C., Sampson N., Merikangas K.R. Improving targets for the prevention of drug use disorders: sociodemographic predictors of transitions across drug use stages in the national comorbidity survey replication. Prev. Med. 2008, 47:629-634.
45. Swendsen J., Conway K.P., Degenhardt L., Dierker L., Glantz M., Jin R., Merikangas K.R., Sampson N., Kessler R.C. Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey. Addiction 2009, 104:1346-1355.
46. Swendsen J., Conway K.P., Degenhardt L., Glantz M., Jin R., Merikangas K.R., Sampson N., Kessler R.C. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 2010, 105:1117-1128.